Intel Is Up 570% in the Past Year. Time to Buy the Comeback Story or Take Profits?

Intel’s stock has surged about 539% over the past year on hopes of a turnaround, supported by capital from the U.S. government and Nvidia and a reported Apple foundry win. But fundamentals remain weak, with Q1 revenue up just 7% year over year and a $3.7 billion net loss, while the stock now trades at 129x forward earnings and 91x 2027 estimates. The article argues the rally may already reflect the turnaround story, making the risk/reward less attractive versus other chip names.

Analysis

The market is no longer pricing Intel as a distressed cyclical; it is pricing it like a long-duration option on a foundry recovery, and that shift creates a setup where good news can still fail if the business doesn’t convert sentiment into operating leverage. The key second-order effect is that external validation from large strategic backers lowers Intel’s financing and customer-acquisition friction, but it also raises the bar: once the balance sheet is implicitly backstopped, every incremental dollar of capital spend must show a path to utilization, or the equity will de-rate fast.

The most interesting beneficiary is actually Apple’s supply-chain flexibility, not Intel itself. Any partial re-routing of volumes toward a second source reduces concentration risk and gives Apple negotiating leverage versus incumbent foundry partners; that pressure can spill over into pricing and capacity commitments across the broader semiconductor supply chain over the next 12–24 months. Nvidia is a more ambiguous positive: support for Intel may help keep an alternative ecosystem alive, but it also seeds a future competitor in a market where packaging, advanced nodes, and AI accelerators are becoming increasingly vertically integrated.

The contrarian miss is duration. The stock is being treated as if a turnaround announcement is a cash-flow inflection, when in reality foundry ramps are multi-year, capex-heavy, and prone to execution slippage. At a premium multiple, Intel does not need merely “progress”; it needs repeated beats on utilization, margin, and customer concentration before the equity’s embedded recovery narrative is justified.

For the rest of semis, the risk is less about direct share loss and more about capital allocation distortion: if Intel’s revival keeps attracting strategic and political support, it can suppress industry discipline and extend capacity overbuild longer than fundamentals warrant. That would be negative for margin quality across the supply chain even if the headline winners look better in the short run.

Key Decisions for Investors

• Fade the move with a short INTC position or put spread over the next 3–6 months; asymmetric risk favors downside if the next two earnings prints fail to show utilization/margin inflection.
• Pair trade: long AAPL / short INTC for 6–12 months; Apple gets supply-chain optionality and bargaining power, while Intel still carries execution risk and heavy capex burden.
• For tactically bullish semis exposure, prefer NVDA over INTC on any 1–3 month pullback; Nvidia benefits from ecosystem entrenchment without needing a foundry turnaround to work.
• If already long INTC, trim into strength and keep only a core position until there is evidence of sustained customer conversion; the stock is priced for success before the operating model has proven it.